We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
92 hedge funds and large institutions have $555M invested in Rocket Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 20 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
95% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.83% less ownership
Funds ownership: 97.57% → 94.74% (-2.8%)
4% less funds holding
Funds holding: 96 → 92 (-4)
20% less call options, than puts
Call options by funds: $340K | Put options by funds: $425K
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
25% less capital invested
Capital invested by funds: $736M → $555M (-$181M)
Holders
92
Holders Change
-4
Holders Change %
-4.17%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
39
Reduced
20
Closed
17
Calls
$340K
Puts
$425K
Net Calls
-$85K
Net Calls Change
+$1.74M
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$32.4M |
| 2 |
BM
Bridger Management
New York
|
-$18.7M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$11.8M |
| 4 |
Millennium Management
New York
|
-$6.61M |
| 5 |
AG
Artal Group
Luxembourg
|
-$5.4M |
